The French bio-pharmaceutical company Hybrigenics has appointed Alain Munoz to its board as a non-executive independent director. Dr Munoz, a trained cardiologist and anaesthesiologist, is an industry veteran, having held senior management jobs in research and development at Sanofi and Fournier. He replaces Bernhard Ehmer, the president of ImClone Systems, who is stepping down from the position. Dr Munoz will also chair the clinical advisory board.
Copyright 2011 Evernow Publishing Ltd